Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Arrowhead Pharmaceuticals (ARWR) over the last 1 years, with Q4 2025 value amounting to $53.2 million.

  • Arrowhead Pharmaceuticals' Treasury Shares changed N/A to $53.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $53.2 million, marking a year-over-year change of. This contributed to the annual value of $53.2 million for FY2025, which is N/A changed from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Treasury Shares of $53.2 million as of Q4 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Treasury Shares ranged from a high of $6.0 million in Q2 2025 and a low of $2.7 million during Q3 2025
  • Over the past 5 years, Arrowhead Pharmaceuticals' median Treasury Shares value was $4.3 million (recorded in 2023), while the average stood at $4.3 million.
  • Within the past 5 years, the most significant YoY rise in Arrowhead Pharmaceuticals' Treasury Shares was 1890.68% (2025), while the steepest drop was 4745.03% (2025).
  • Quarter analysis of 5 years shows Arrowhead Pharmaceuticals' Treasury Shares stood at $3.6 million in 2021, then rose by 10.63% to $4.0 million in 2022, then rose by 15.65% to $4.6 million in 2023, then rose by 10.45% to $5.1 million in 2024, then tumbled by 47.45% to $2.7 million in 2025.
  • Its Treasury Shares stands at $2.7 million for Q4 2025, versus $2.7 million for Q3 2025 and $6.0 million for Q2 2025.